Report Description

India losartan market is expected to grow at a steady rate during the forecast period. The India losartan market is driven by high growth in incidence of cardiovascular diseases in India. Additionally, favourable schemes of the government of the country for manufacturing, promotion and development of drugs, intermediates, and active pharmaceutical ingredients is further estimated to drive the market growth. Also, the dose is recommended for treating diabetic nephropathy with higher serum creatinine and proteinuria in patients with type 2 diabetes. This is further expected to boost the demand through FY2026.

The India Losartan market is segmented based on source, form, strength, distribution channel, application, end user, company, and region. Based on distribution channel, the market can be segmented into online and offline. The offline channel is expected to dominate the market due to surging consumer preference for purchasing medicines from a pharmacy or drug store. The online segment is also expected to register significant growth over the next few years. This can be ascribed to the fact that buying from online pharmacy is extremely helpful for those who lead busy lifestyles and simply do not have the time in the day to visit the local pharmacy.

The major players operating in the India losartan market are Alembic Pharmaceuticals Ltd, Torrent Pharmaceutical Ltd., Lupin Ltd., Teva API India Ltd., Novartis India Ltd., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceuticals Industries Ltd., Taj Pharmaceuticals Ltd., Anuh Pharma Ltd., and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, portfolio expansion and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India losartan market from FY2016 to FY2019.
  • To estimate and forecast the market size of India losartan market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India losartan market based on source, form, strength, distribution channel, application, end user, company, and regional distribution.
  • To identify dominant region or segment in the India losartan market.
  • To identify drivers and challenges for India losartan market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India losartan market.
  • To identify and analyze the profile of leading players operating in India losartan market.
  • To identify key sustainable strategies adopted by market players in India losartan market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India losartan market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Losartan manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to losartan

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India losartan market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Losartan Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Losartan Market, By Form:
    • Tablet
    • Capsule
    • Others
  • India Losartan Market, By Strength:
    • 25 mg
    • 50 mg
    • 100 mg
    • Others
  • India Losartan Market, By Distribution Channel:
    • Online
    • Offline
  • India Losartan Market, By Application:
    • Hypertension
    • Stroke
    • Diabetic Nephropathy
    • Others
  • India Losartan Market, By End User:
    • Adult
    • Paediatric
  • India Losartan Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India losartan market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India losartan market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Losartan Market

4.    Executive Summary

5.    Manufacturing Losartan

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Losartan

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Losartan Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.2.     By Form (Tablet, Capsule, Others)

7.2.3.     By Strength (25 mg, 50 mg, 100 mg, Others)

7.2.4.     By Distribution Channel (Online v/s Offline)

7.2.5.     By Application (Hypertension, Stroke, Diabetic Nephropathy, Others)

7.2.6.     By End User (Adult v/s Paediatric)

7.2.7.     By Region (North, East, South, West)

7.2.8.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Alembic Pharmaceuticals Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Torrent Pharmaceutical Ltd.

14.1.3.  Lupin Ltd.

14.1.4.  Teva API India Ltd.

14.1.5.  Novartis India Ltd.

14.1.6.  Aurobindo Pharma Ltd.

14.1.7.  Dr. Reddy’s Laboratories Ltd.

14.1.8.  Sun Pharmaceuticals Industries Ltd.

14.1.9.  Taj Pharmaceuticals Ltd.

14.1.10.                Anuh Pharma Ltd.

15.  Strategic Recommendations

16. About Us & Disclaimer 

Figures and Tables

Frequently asked questions